Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-04

Clinical Trial Update: Long Term Follow up in Sickle Cell Patients Treated by Hydroxyurea

View source ↗

Summary

This clinical trial update presents long-term follow-up data for sickle cell patients treated with hydroxyurea, focusing on safety and sustained efficacy. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Sickle Cell Anemia, Sickle Cell Thalassemia | Status: COMPLETED